New array strategies using C-H borylation chemistry
Lead Research Organisation:
Durham University
Department Name: Chemistry
Abstract
In order to evaluate and optimise (small) molecules for a particular function, e.g. as a drug molecule, it is necessary to prepare a range of analogues that differ in structure. This is known as an array and the efficient synthesis of such arrays requires reactions that can be used on multiple samples simultaneously. The variety of chemical reactions currently used in array preparation is limited and the research in this project is designed to address this need based on chemistry of the boronic acid functional group. In particular we will develop new array synthetic strategies using direct catalytic C-H borylation chemistry. This requires evaluation of new substrate classes and an optimisation of the catalysts to give better selectivity and reactivity. This will provide sets of new boronic acids from unfunctionalised aromatic and heteroaromatic precursors. In addition, the boronic acids are themselves used in many synthetic transformations and we will explore using the arrays of boronic acids as starting points for a further generation of array synthesis.
Publications
Tajuddin H
(2012)
Iridium-catalyzed C-H borylation of quinolines and unsymmetrical 1,2-disubstituted benzenes: insights into steric and electronic effects on selectivity
in Chemical Science
Sadler SA
(2014)
Iridium-catalyzed C-H borylation of pyridines.
in Organic & biomolecular chemistry
Tajuddin H
(2010)
"One-pot" tandem C-H borylation/1,4-conjugate addition/reduction sequence.
in Organic letters
Sadler SA
(2015)
Multidirectional Synthesis of Substituted Indazoles via Iridium-Catalyzed C-H Borylation.
in The Journal of organic chemistry
Description | C-H borylation can be an efficient method for the late stage generation of analogues of drug like molecules - pharmaceutical leads |
Exploitation Route | similar transformations are now being used in other drug discovery programmes |
Sectors | Pharmaceuticals and Medical Biotechnology |
Description | used at GSK by DU researcher on placement to explore library enrichment strategies - reported in primary literature |
First Year Of Impact | 2012 |
Sector | Pharmaceuticals and Medical Biotechnology |
Description | Astra Zeneca Case Award |
Amount | £24,000 (GBP) |
Organisation | AstraZeneca |
Sector | Private |
Country | United Kingdom |
Start | 09/2012 |
End | 09/2015 |
Description | CASE collaboration with GSK |
Organisation | GlaxoSmithKline (GSK) |
Country | Global |
Sector | Private |
PI Contribution | Academic research results |
Collaborator Contribution | Intellectual input - Industrial supervision - industrial secondment |
Impact | None yet |
Start Year | 2013 |